ATLAS / Macro Radar / Reporting / MDCX

Medicus Pharma Ltd. (MDCX) reporting calendar

Medicus Pharma Ltd. files periodic reports with the SEC as MDCX on Nasdaq. Atlas tracks 6 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
22 Jul 2026 – 4 Sep 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
14 May 2026
Reports on record
6

How this window is derived. Derived from this issuer's own filing history: 6 periods at a median 91-day cadence, filed a median 44 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open MDCX market profile Latest filing on SEC EDGAR ↗ Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 202614 May 202644 days0001062993-26-002629
10-K31 Dec 202525 Mar 202684 days0001062993-26-001606
10-Q30 Sep 202514 Nov 202545 days0001062993-25-016838
10-Q30 Jun 202511 Aug 202542 days0001062993-25-014058
10-Q31 Mar 202512 May 202542 days0001062993-25-009125
10-K31 Dec 202428 Mar 202587 days0001062993-25-006485

Source: SEC EDGAR company submissions for CIK 0001997296. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.